The current INTS market cap is 69.92M. The company's latest EPS is USD -0.8652 and P/E is -5.91.
Quarter End | Dec 2021 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -2.41M | -1.25M | -1.22M | -2.49M | -3.35M |
Net Income | -2.4M | -1.34M | -3.7M | -3.65M | -3.17M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -5.68M | -6.22M | -8.01M | -7.63M | -8.32M |
Net Income | -5.38M | -6.03M | -7.9M | -7.58M | -11.86M |
Quarter End | Dec 2021 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 5.22M | 951k | 18.23M | 16.82M | 17.3M |
Total Liabilities | 3.9M | 6.91M | 3.09M | 905k | 4.13M |
Total Equity | -8.68M | -15.96M | 15.13M | 15.91M | 13.16M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 8.93M | 10.15M | 5.22M | 1.76M | 17.3M |
Total Liabilities | 1.31M | 1.71M | 3.9M | 6.85M | 4.13M |
Total Equity | -2.38M | -1.56M | -8.68M | -15.1M | 13.16M |
Quarter End | Dec 2021 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -6.83M | -900k | -1.14M | -6.26M | -7.21M |
Investing | N/A | N/A | N/A | -8.84M | -6.02M |
Financing | 2.05M | 205k | -37k | 20.48M | 20.47M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -4.42M | -5.37M | -6.83M | -5.48M | -7.21M |
Investing | 1.7M | 4.57M | N/A | N/A | -6.02M |
Financing | 3.86M | 6.29M | 2.05M | 2.25M | 20.47M |
Market Cap | 69.92M |
Price to Earnings Ratio | -5.91 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 8.19 |
Price to Book Ratio | 5.32 |
Dividend Yield | - |
Shares Outstanding | 13.71M |
Average Volume (1 week) | 41.44k |
Average Volume (1 Month) | 15.06k |
52 Week Change | -14.29% |
52 Week High | 11.44 |
52 Week Low | 2.0101 |
Spread (Intraday) | 0.37 (6.76%) |
Company Name | Intesity Therapeutics Inc |
Address |
251 little falls drive wilmington, delaware 19808 |
Website | https:// |
Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.